Did you know that molecular hydrogen might hold the key to maintaining heart health and potentially reducing the risk of coronary artery disease (CAD)?
Here’s what we know…
According the WHO, 17.7 million deaths have been attributed (you read that right) to heart disease around the globe.
And as you may know, this statistic is only growing faster with each passing year.
Chronic ailments like coronary atherosclerotic heart disease (CHD), also known as coronary artery disease (CAD), pose a daunting challenge to on a global scale.
What’s causing heart complications to skyrocket?
Most complications are triggered by risk factors like…
- High blood pressure
- Chronic kidney disease
- Lifestyle choices
- Stress
- And much more.
The problem is, CAD restricts blood flow in the arteries leading to the heart.
But there is a potential solution to fight the symptoms.
Believe it or not, it’s molecular hydrogen.
Molecular hydrogen (H2)—act like a selective antioxidant and metabolic regulator.
This unique combination has sparked enthusiasm in the medical community for one simple reason which we’ll get to in a moment…
Atherosclerosis: The Hidden Risk Factor for Heart Disease
Here’s the problem…
Coronary atherosclerosis happens when plaque builds up within the artery walls.
Unfortunately, plaque buildup narrows arteries and restricts blood flow.
And if blood flow becomes restricted… Blood pressure goes up.
Ignore this scenario too long and you get the picture.
It could send you on an ambulance ride the the emergency room.
So what’s the solution?
This is where scientists are looking to bridge the gap.
Enter…
Molecular Hydrogen: Potential Anti-Inflammatory Agent for CAD
Molecular hydrogen has exhibited “potential” as an effective anti-inflammatory agent.
(Remember, hydrogen functions as a selective antioxidant AND a metabolic regulator.)
Here’s how it works. When hydrogen enters the body it can…
- Help regulate critical cellular pathways including NF-κB, PI3K and AMPK, to help soothe inflammation.
- And help the body regulate arterial plaque by targeting glycolipid metabolism.
Of course while hydrogen show promise for on-going heart protection. This is doesn’t not suggest hydrogen is a cure. Further testing and studies are needed.
Conclusion:
While conventional treatments for coronary artery disease have limitations, H2 therapy appears as a hopeful option with promising findings in clinical studies, even for patients experiencing chest pain or at high risk of heart failure.
The application of molecular hydrogen could signify a new frontier in cardiovascular healthcare. We must consider how this simple molecule could contribute to managing coronary heart disease in the future. Advocating for further clinical trials and standardized protocols could expedite H2’s integration into CHD treatment strategies. However, more research is needed.
While molecular hydrogen exhibits promise, we must clarify that it’s not a cure-all. We are not suggesting hydrogen will cure CAD or reverse any health complications.
Please consult with your doctor before incorporating hydrogen into your daily routine.
Study Reference:
The role of hydrogen in the prevention and treatment of coronary atherosclerotic heart disease.
Authors:
Yunxi Chen, Youzhen Wei, Wenjie Tang
Abstract:
Coronary atherosclerotic heart disease (CHD) is a primary cardiovascular disease caused by atherosclerosis (AS), which is characterized by chronic inflammation and lipid oxidative deposition. Molecular hydrogen (H2) is an effective anti-inflammatory agent and has potential to ameliorate glycolipid metabolism disorders, which is believed to exert beneficial effects on the prevention and treatment of CHD. It is suggested that H2 reduces inflammation in CHD by regulating multiple pathways, including NF-κB inflammatory pathway, pyroptosis, mitophagy, endoplasmic reticulum (ER) stress, and Nrf2 antioxidant pathway. Additionally, H2 may improve glycolipid metabolism by mediation of PI3K and AMPK signalling pathways, contributing to inhibition of the occurrence and development of CHD. This review elaborates pathogenesis of CHD and evaluates the role of H2 in CHD. Moreover, possible molecular mechanisms have been discussed and speculated, aiming to provide more strategies and directions for subsequent studies of H2 in CHD.
